VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+21.76%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.27B
AUM Growth
+$51.2M
(+4.2%)
Cap. Flow
-$76.9M
Cap. Flow
% of AUM
-6.05%
Top 10 Holdings %
Top 10 Hldgs %
71.44%
Holding
50
New
3
Increased
6
Reduced
7
Closed
8
Top Buys
1 |
SVA
Sinovac Biotech, Ltd
SVA
|
+$76.3M |
2 |
Adverum Biotechnologies
ADVM
|
+$21.2M |
3 |
Dyne Therapeutics
DYN
|
+$17M |
4 |
RGLS
Regulus Therapeutics
RGLS
|
+$14.4M |
5 |
SLN
Silence Therapeutics
SLN
|
+$12.9M |
Top Sells
1 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
+$95.8M |
2 |
Tarsus Pharmaceuticals
TARS
|
+$44.3M |
3 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
+$26.9M |
4 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
+$11.9M |
5 |
Apogee Therapeutics
APGE
|
+$11.2M |
Sector Composition
1 | Healthcare | 100% |